Cancer and multiple sclerosis patients insured by Medicare are among those awaiting lower drug prices from the Inflation Reduction Act.
This article is available to Insider Pro subscribers only. Sign in or register to be an Insider Pro and access ALL LOCKED articles.
The U.S. economy does not lose momentum
Savvy Senior: How the Inflation Reduction Act will lower your drug costs
Username
Password
Remember Me
The U.S. economy does not lose momentum
Savvy Senior: How the Inflation Reduction Act will lower your drug costs
Advisor News
- Americans’ saving, investment product savvy improves, study finds
- Bull or bear? What are financial advisors’ market expectations for 2025?
- Panel: Is the American retirement system ‘broken’?
- Goldman Sachs, others weigh in on what’s ahead for the market in 2025
- How is consumers’ investing confidence impacting the need for advisors?
More Advisor NewsAnnuity News
Health/Employee Benefits News
- OPINION: Colorado must be a trailblazer on youth mental health services and solve the commercial insurance problem
- West Virginians say medications have helped them lose weight, but coverage can be a problem
- A Yankee Notebook: The public-private schism
- Insurance is what makes US health-care prices so high
- Gov. Hochul signs legislation to cap out-of-pocket costs for EpiPen devices
More Health/Employee Benefits NewsLife Insurance News